1. Inicio
  2. Proyectos y Estudios
  3. ESTUDIO CLINICO COMPARATIVO DE UNA NUEVA FORMULACION DEPOT DE LEUPRORELINA 11,25MG (A18-3M) VERSUS UNA FORMULACION DEPOT DE DEUPRORELINA 11,25 MG DE REFERENCIA, EN PACIENTES CON CANCER DE PROSTATA QUE PUEDEN BENEFICIARSE DE UN BLOQUEO HORMONAL ANDROGENICO, ESTUDIO MULTICENTRICO, RANDOMIZADO, CONTROLADO, NO CIEGO Y EN DOS GRUPOS PARALELOS.

ESTUDIO CLINICO COMPARATIVO DE UNA NUEVA FORMULACION DEPOT DE LEUPRORELINA 11,25MG (A18-3M) VERSUS UNA FORMULACION DEPOT DE DEUPRORELINA 11,25 MG DE REFERENCIA, EN PACIENTES CON CANCER DE PROSTATA QUE PUEDEN BENEFICIARSE DE UN BLOQUEO HORMONAL ANDROGENICO, ESTUDIO MULTICENTRICO, RANDOMIZADO, CONTROLADO, NO CIEGO Y EN DOS GRUPOS PARALELOS.

Datos básicos

Protocolo:
A1803MIN201
EUDRACT:
NO ENCUENTRO
NCT:
Centro:
Año de incio:
Año de finalización:
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Financiadores - Promotores

PIERRE FABRE IBERICA S.A.

Resultados del Ensayo Clínico

Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro.

Herranz R; (...); Medina P

Article. 10.3389/fimmu.2023.1171065. 2023

  • Open Access.

Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients.

Arevalo Ruales, Karla; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.medcli.2022.03.026. 2023


Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs

Oto J; (...); Medina P

Article. 10.3390/ijms22157913. 2021

  • Open Access.

Nuclear-medicine probes: Where we are and where we are going

Gonzalez-Montoro A; (...); Javier Gonzalez, Antonio

Article. 10.1002/mp.15690. 2022

  • Open Access.

Prostate cancer chemotherapy by intratumoral administration of Docetaxel-Mesoporous silica nanomedicines.

Rivero-Buceta, Eva; (...); Botella, Pablo

Article. 10.1016/j.ijpharm.2024.124623. 2024

  • Open Access.

Sildenafil Citrate Enhances Renal Organogenesis Following Metanephroi Allotransplantation into Non-Immunosuppressed Hosts.

Garcia-Dominguez, Ximo; (...); Marco-Jimenez, Francisco

Article. 10.3390/jcm11113068. 2022

  • Open Access.

The sentinel node with technetium-99m for prostate cancer. A safe and, mature new gold standard?

Perez-Ardavin J; (...); Vera-Donoso CD

Article. 10.23736/S1824-4785.22.03416-1. 2022


Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker

Oto, Julia; (...); Medina, Pilar

Article. 10.1016/j.jprot.2024.105357. 2025


Campos de Estudio

Compartir